Execs named, Williams DARTs in as CEO
This article was originally published in Scrip
Executive Summary
DART Therapeutics which is focused on developing therapies for Duchenne muscular dystrophy, has formed its executive team. Co-Founder and executive chairman Eugene Williams transitions to a full-time role as CEO, and Dr Ernest Bush joins as CSO. DART also added Dr Elliot Goldstein as chief medical officer and Cabot Brown as chief financial officer.